Abstract
Two mammalian DNA polymerase β (pol β) inhibitors have been isolated independently from the brown algae Laminaria sp. These molecules were determined by spectroscopic analyses to be a loliolide derivative, 2,3a-dihydroxy- 4,4,6,7a-tetramethyl-3-oxo-octahydro-1-benzofuran-6-yl acetate (compound 1), and pubinernoid A (compound 2). Compounds 1 and 2 selectively inhibited the activity of rat pol β, and 50% inhibition was observed at concentrations of 18.4 and 38.8 µ M, respectively. By contrast, these compounds did not influence the activity of 10 other mammalian pols [pols α, γ, δ, , η, ι, κ, λ, μ and terminal deoxynucleotidyl transferase (TdT)] tested, and showed no effect even on the activity of fish pol δ, plant pols α and λ, prokaryotic pols, or any other DNA or RNA metabolic enzymes tested. Inhibition of rat pol β activity by compounds 1 and 2 was competitive with both DNA template-primer and nucleotide substrate. The structure- activity relationship of these compounds is discussed.
Keywords: Loliolide derivative, Pubinernoid A, Enzyme inhibitor, DNA polymerase β, Computer simulation, Anti-cancer agents, deoxyribonucleotides, Eukaryotic cells, replicative pols (a, d and e), mitochondrial pol g, terminal deoxynucleotidyl transferase (TdT), C-terminus, Laminaria sp, Histidine-tagged enzyme, Molt-4, E. coli
Letters in Drug Design & Discovery
Title: DNA Polymerase β Specific Inhibitors, a Loliolide Derivative and Pubinernoid A, Isolated from the Brown Algae Laminaria sp.
Volume: 8 Issue: 8
Author(s): Yoshiyuki Mizushina, Toshifumi Takeuchi, Isoko Kuriyama, Yoshihiro Takahashi, So Maezawa, Takuro Matsumoto, Osamu Koiwai, Fumio Sugawara and Hiromi Yoshida
Affiliation:
Keywords: Loliolide derivative, Pubinernoid A, Enzyme inhibitor, DNA polymerase β, Computer simulation, Anti-cancer agents, deoxyribonucleotides, Eukaryotic cells, replicative pols (a, d and e), mitochondrial pol g, terminal deoxynucleotidyl transferase (TdT), C-terminus, Laminaria sp, Histidine-tagged enzyme, Molt-4, E. coli
Abstract: Two mammalian DNA polymerase β (pol β) inhibitors have been isolated independently from the brown algae Laminaria sp. These molecules were determined by spectroscopic analyses to be a loliolide derivative, 2,3a-dihydroxy- 4,4,6,7a-tetramethyl-3-oxo-octahydro-1-benzofuran-6-yl acetate (compound 1), and pubinernoid A (compound 2). Compounds 1 and 2 selectively inhibited the activity of rat pol β, and 50% inhibition was observed at concentrations of 18.4 and 38.8 µ M, respectively. By contrast, these compounds did not influence the activity of 10 other mammalian pols [pols α, γ, δ, , η, ι, κ, λ, μ and terminal deoxynucleotidyl transferase (TdT)] tested, and showed no effect even on the activity of fish pol δ, plant pols α and λ, prokaryotic pols, or any other DNA or RNA metabolic enzymes tested. Inhibition of rat pol β activity by compounds 1 and 2 was competitive with both DNA template-primer and nucleotide substrate. The structure- activity relationship of these compounds is discussed.
Export Options
About this article
Cite this article as:
Mizushina Yoshiyuki, Takeuchi Toshifumi, Kuriyama Isoko, Takahashi Yoshihiro, Maezawa So, Matsumoto Takuro, Koiwai Osamu, Sugawara Fumio and Yoshida Hiromi, DNA Polymerase β Specific Inhibitors, a Loliolide Derivative and Pubinernoid A, Isolated from the Brown Algae Laminaria sp., Letters in Drug Design & Discovery 2011; 8 (8) . https://dx.doi.org/10.2174/157018011796576024
DOI https://dx.doi.org/10.2174/157018011796576024 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Evolution of Clostridium difficile Infection in Cancer Patients: Epidemiology, Pathophysiology, and Guidelines for Prevention and Management
Recent Patents on Anti-Infective Drug Discovery Deregulation of the Mitochondrial Apoptotic Machinery and Development of Molecular Targeted Drugs in Acute Myeloid Leukemia
Current Cancer Drug Targets Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules
Current Medicinal Chemistry Inhibitors of Chronically Active Ras: Potential for Treatment of Human Malignancies
Recent Patents on Anti-Cancer Drug Discovery IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine
Current Pharmaceutical Design The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?
Current Drug Targets The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology
Current Medicinal Chemistry Overview of Mechanisms of Cancer Stem Cell Drug Resistance
Current Signal Transduction Therapy Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment
Current Pharmaceutical Design Omalizumab: Not Only For Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Cancer Chemoprevention by Targeting the Epigenome
Current Drug Targets Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Toll-Like Receptors in Alzheimer's Disease: A Therapeutic Perspective
CNS & Neurological Disorders - Drug Targets Invasive aspergillosis: adjunctive combination therapy
Mini-Reviews in Medicinal Chemistry The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery MicroRNAs as Regulators in Normal Hematopoietic and Leukemia Stem Cells: Current Concepts and Clinical Implications
Current Molecular Medicine Marine Sponges: Potential Sources of New Antimicrobial Drugs
Current Pharmaceutical Biotechnology The Interaction of Histone Deacetylase Inhibitors and DNA Methyltransferase Inhibitors in the Treatment of Human Cancer Cells
Current Medicinal Chemistry - Anti-Cancer Agents Ansamycin Inhibitors of Hsp90: Natures Prototype for Anti-Chaperone Therapy
Current Topics in Medicinal Chemistry